| Status | Study |
| Recruiting |
Study Name: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer Condition: Endometrial Cancer Endometrial Carcinosarcoma Endometrial Date: 2017-01-04 Interventions: Drug: Durvalumab Drug: Tremelimumab |
| Not yet recruiting |
Study Name: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 Condition: Carcinosarcoma, Ovarian Carcinosarcomas Uterine Date: 2016-12-01 Interventions: Drug: Trabectedin Other Name: Yondelis |
| Recruiting |
Study Name: Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer Condition: Breast Carcinoma Endometrial Carcinoma Prostate Carcinosar Date: 2016-11-14 Interventions: Dietary Supplement: Dietary Intervention |
| Not yet recruiting |
Study Name: microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer Condition: Prostate Carcinosarcoma Date: 2016-11-08 Interventions: Biological: High PSA levels |
| Recruiting |
Study Name: Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer Condition: Breast Carcinoma Endometrial Clear Cell Adenocarcinoma End Date: 2016-08-17 Interventions: Drug: Metformin Hydrochloride |
| Not yet recruiting |
Study Name: Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection Condition: Mixed Tumor, Malignant Biopsy Date: 2016-07-28 Interventions: Device: Optical Coherence Tomography (OCT) with Vivosight |
| Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
| Recruiting |
Study Name: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Date: 2014-05-05 Interventions: Drug: Pazopanib plus Gemcitabine |
| Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Date: 2014-03-28 Interventions: Drug: Gemcitabine Hydrochloride |
| No longer available |
Study Name: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient Condition: Mullerian Mixed Tumor of Ovary Date: 2014-03-14 Interventions: Drug: ficlatuzumab humanized anti-hepatocyte growth factor (HGF) monoclonal antibody IV administration a |